HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N epsilon-(carboxymethyl)lysine during the early development of hypertension.

Abstract
Advanced glycation end products (AGEs) are associated with hypertension. Whether N(epsilon)-(carboxymethyl)lysine (CML) contributes to the development of hypertension in young spontaneously hypertensive rats (SHR) remains to be established compared to WKY. We determined blood pressure, renal function, marker for oxidative stress (OS), and CML in young WKY rats and SHR. We found blood pressure was increased in SHR with no difference in renal function and OS compared to WKY. CML was elevated in plasma (2.3 +/- 0.3 vs. 1.3 +/- 0.2 micromol/L) and kidney (1.0 +/- 0.1 vs. 0.5 +/- 0.1 micromol/L) compared to WKY. Early CML accumulation may contribute to the development of hypertension potentially by inducing early renal inflammation independent of glomerular dysfunction or oxidative stress.
AuthorsMarcus Baumann, Coen Stehouwer, Jean Scheijen, Uwe Heemann, Harry Struijker Boudier, Casper Schalkwijk
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 1126 Pg. 201-4 (Apr 2008) ISSN: 0077-8923 [Print] United States
PMID18079484 (Publication Type: Journal Article)
Chemical References
  • Glycation End Products, Advanced
  • N(6)-carboxymethyllysine
  • Creatinine
  • Lysine
Topics
  • Albuminuria
  • Animals
  • Blood Pressure
  • Creatinine (metabolism)
  • Glycation End Products, Advanced (metabolism)
  • Heart Rate
  • Humans
  • Hypertension (physiopathology)
  • Lysine (analogs & derivatives, metabolism)
  • Oxidative Stress
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: